Amgen Inc. BDR (AMGN34) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +0,36%	1 096,72	+3,98	+0,36%	—	1 092,74	1 095,95	1 103,32	1 094,72	—	—
SIXC Communications SIXC Communications	SIXC −0,33%	611,32	−2,04	−0,33%	—	613,36	613,36	613,36	609,50	—	—
SIXE Energy SIXE Energy	SIXE −0,45%	1 171,54	−5,25	−0,45%	—	1 176,79	1 176,52	1 182,25	1 166,69	—	—
SIXI Industrials SIXI Industrials	SIXI −0,45%	1 747,63	−7,91	−0,45%	—	1 755,54	1 759,23	1 766,30	1 746,04	—	—
SIXM Financials SIXM Financials	SIXM −0,58%	631,49	−3,66	−0,58%	—	635,15	635,20	636,89	630,09	—	—
SIXR Staples SIXR Staples	SIXR +0,23%	849,94	+1,93	+0,23%	—	848,01	852,52	855,78	849,58	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0,09%	218,06	+0,20	+0,09%	—	217,86	217,86	219,52	217,86	—	—
SIXT Technology SIXT Technology	SIXT +3,47%	3 536,03	+118,68	+3,47%	—	3 417,35	3 452,77	3 536,03	3 450,39	—	—
SIXU Utilities SIXU Utilities	SIXU −0,91%	905,07	−8,29	−0,91%	—	913,36	915,10	920,43	904,57	—	—
SIXV Health care SIXV Health care	SIXV −0,86%	1 449,86	−12,52	−0,86%	—	1 462,38	1 461,13	1 464,53	1 446,02	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,30%	2 430,47	+7,33	+0,30%	—	2 423,14	2 428,71	2 448,69	2 424,63	—	—

AMGN34:BVMF

Amgen Inc. BDR

57,88 BRL

+0,10%

(+0,060) 1 D

8. mai, 16:56:00 GMT-3 · BRL

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for AMGN34 …

Åpne

57,82 BRL

Høy

57,88 BRL

Lav

57,82 BRL

Markedsverdi

179,02 mrd.

Snittvolum

618,00

Volum

69,00

52 u høy

77,81 BRL

52 u lav

48,20 BRL

Utestående aksjer

539,71 mill.

Antall ansatte

32k

Relaterte aksjer

Nyhetssaker

Fra kilder på nettet

Simply Wall Street

for 4 timer siden

Is It Time To Reassess Amgen (AMGN) After A Steady Share Price And Strong DCF Case

The Motley Fool

for 11 timer siden

2 Dividend Stocks to Double Up On Right Now

Trefis

for 12 timer siden

Is Amgen Stock Poised for a Rally?

MarketBeat

for 20 timer siden

GRIMES & Co WEALTH MANAGEMENT LLC Sells 4,111 Shares of Amgen Inc. $AMGN

Profil

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis. Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection. The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia

Om Amgen Inc. BDR

Administrerende direktørRobert A. Bradway

Ansatte31,5k

Grunnlagt8. apr. 1980

HovedkontorThousand Oaks, California, USA

Sektor-

Nettstedamgen.com

Alle verdier i USD	juni 2025	sep. 2025	des. 2025	mars 2026
Inntekt	9,18 mrd.	9,56 mrd.	9,87 mrd.	8,62 mrd.
Varekostnad	2,67 mrd.	2,74 mrd.	2,68 mrd.	2,50 mrd.
Direkte driftskostnader	2,67 mrd.	2,74 mrd.	2,68 mrd.	2,50 mrd.
Utgifter til forskning og utvikling	1,74 mrd.	1,90 mrd.	2,14 mrd.	1,72 mrd.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	1,69 mrd.	1,72 mrd.	1,95 mrd.	1,60 mrd.
Driftskostnader	3,50 mrd.	3,55 mrd.	4,18 mrd.	3,21 mrd.
Totale driftskostnader	6,18 mrd.	6,29 mrd.	6,85 mrd.	5,70 mrd.
Driftsinntekter	3,00 mrd.	3,26 mrd.	3,01 mrd.	2,91 mrd.
Andre ikke-operasjonelle inntekter	−113,00 mill.	181,00 mill.	143,00 mill.	192,00 mill.
EBT inkludert uvanlige elementer	1,57 mrd.	3,92 mrd.	1,51 mrd.	2,08 mrd.
EBT uten uvanlige elementer	2,37 mrd.	2,72 mrd.	2,51 mrd.	2,37 mrd.
Kostnad for inntektsskatt	136,00 mill.	705,00 mill.	181,00 mill.	265,00 mill.
Faktisk avgiftssats	8,67 %	17,98 %	11,96 %	12,72 %
Andre driftskostnader	68,00 mill.	−71,00 mill.	82,00 mill.	−113,00 mill.
Nettoinntekt	1,43 mrd.	3,22 mrd.	1,33 mrd.	1,82 mrd.
Netto fortjenestemargin	15,60 %	33,65 %	13,51 %	21,11 %
Resultat per aksje	6,02	5,64	5,29	5,15
Rente- og investeringsinntekter	-	-	408,00 mill.	-
Rentekostnader	−694,00 mill.	−685,00 mill.	−1,06 mrd.	−657,00 mill.
Netto rentekostnader	−694,00 mill.	−685,00 mill.	−653,00 mill.	−657,00 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	4,34 mrd.	4,57 mrd.	4,02 mrd.	4,03 mrd.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning